DCPH

Deciphera Pharmaceuticals, Inc.

About DCPH

Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and delivering medicines to patients for the treatment of cancer. The Company has developed a switch-control kinase inhibitor platform in kinase biology to execute its strategy to develop a broad portfolio of medicines. The Company has one approved drug, QINLOCK, which is a switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). In addition, the Company is developing three clinical-stage drug candidates, which includes Vimseltinib (DCC-3014) - colony stimulating factor 1 receptor (CSF1R) Kinase Inhibition for Tenosynovial Giant Cell Tumor (TGCT), Rebastinib - TEK tyrosine kinase (TIE2) Kinase Inhibition for advanced or Metastatic Solid Tumors, and DCC-3116 - ULK Kinase Inhibition for Mutant RAS/RAF Cancers.

Buy US stocks in Australia starting with DCPH. Open an account and start investing today!

Market Capitalisation

$1.34B

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$19.14

Low today

$17.69

Open price

$0.00

52-week high

$22.76

52-week low

$6.51

DCPH FAQs

How much is one share of Deciphera Pharmaceuticals, Inc.?

One share of Deciphera Pharmaceuticals, Inc. is valued at $17.87.

What is the ticker symbol for Deciphera Pharmaceuticals, Inc.?

The ticker symbol for Deciphera Pharmaceuticals, Inc. is DCPH.

How do I buy DCPH shares in Australia?

To buy DCPH stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in DCPH

What is the market capitalisation of Deciphera Pharmaceuticals, Inc. DCPH?

As of 26/01/2023 Deciphera Pharmaceuticals, Inc. has a market cap of $1.3B.

What is the 52-week high for Deciphera Pharmaceuticals, Inc. stock?

The Deciphera Pharmaceuticals, Inc. 52-week high stock price is $22.76.

What is the 52-week low for Deciphera Pharmaceuticals, Inc. stock?

The Deciphera Pharmaceuticals, Inc. 52-week low stock price is $6.51.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.